Senti Biosciences Inc Financial Flexibility Index
Senti Biosciences Inc financial flexibility index. Senti Biosciences Inc (SNTI) has a Financial Flexibility Index of -0.21x as of September 2025. Free cash flow of $-9.45 Million (operating CF $-9.45 Million minus capex $0.00) represents 0% of total liabilities ($44.56 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Senti Biosciences Inc (2019–2024)
Financial flexibility index of Senti Biosciences Inc from 2019 to 2024. Historical Financial Flexibility Index trend for Senti Biosciences Inc across 6 annual periods. Explore Senti Biosciences Inc (SNTI) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Senti Biosciences Inc Financial Flexibility Index by Year (2019–2024)
Senti Biosciences Inc financial flexibility index by year from 2019 to 2024. Year-by-year free cash flow to debt coverage for Senti Biosciences Inc. For the full cash flow conversion analysis, see SNTI cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.57x | $-41.37 Million | $-41.40 Million | $72.19 Million | ▲ +25.3% |
| 2023 | -0.77x | $-40.36 Million | $-52.40 Million | $52.57 Million | ▼ -734.3% |
| 2022 | 0.12x | $6.48 Million | $-34.90 Million | $53.53 Million | ▲ +115.1% |
| 2021 | -0.80x | $-29.09 Million | $-34.63 Million | $36.33 Million | ▼ -272.6% |
| 2020 | -0.21x | $-23.01 Million | $-24.17 Million | $107.06 Million | ▲ +76.5% |
| 2019 | -0.92x | $-16.38 Million | $-18.38 Million | $17.88 Million | — |